RET and multiple endocrine neoplasia type 2: Regarding the etiology of multiple endocrine neoplasia type 2 (MEN2) syndrome, the responsible genetic mutation is represented by the activating mutation of the receptor tyrosine kinase, also known as the rearranged during transfection (RET) protein, which is located on chromosome 10q.